Literature DB >> 19950421

EFNS guidelines on the molecular diagnosis of mitochondrial disorders.

J Finsterer1, H F Harbo, J Baets, C Van Broeckhoven, S Di Donato, B Fontaine, P De Jonghe, A Lossos, T Lynch, C Mariotti, L Schöls, A Spinazzola, Z Szolnoki, S J Tabrizi, C M E Tallaksen, M Zeviani, J-M Burgunder, T Gasser.   

Abstract

OBJECTIVES: These European Federation of Neurological Sciences (EFNS) guidelines are designed to provide practical help for the general neurologist to make appropriate use of molecular genetics for diagnosing mitochondrial disorders (MIDs), which gain increasing attention and are more frequently diagnosed due to improved diagnostic tools.
BACKGROUND: Since the publication of the first EFNS guidelines on the molecular diagnosis of inherited neurological diseases in 2001, rapid progress has been made in this field, necessitating the creation of an updated version. SEARCH STRATEGY: To collect data about the molecular diagnosis of MIDs search for literature in various electronic databases, such as Cochrane library, MEDLINE, OMIM, GENETEST or Embase, were carried out and original papers, meta-analyses, review papers, and guideline recommendations were reviewed.
RESULTS: The guidelines summarise the possibilities and limitations of molecular genetic diagnosis of MIDs and provide practical recommendations and diagnostic criteria in accordance with the EFNS Scientific Committee to guide the molecular diagnostic work-up of MIDs. RECOMMENDATIONS: The proposed guidelines suggest an approach to the molecular diagnosis of MIDs in a manner accessible to general neurologists.

Entities:  

Mesh:

Year:  2009        PMID: 19950421     DOI: 10.1111/j.1468-1331.2009.02811.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  16 in total

1.  Cardiac arrest in kearns-sayre syndrome.

Authors:  Ingrid van Beynum; Eva Morava; Marjan Taher; Richard J Rodenburg; Judit Karteszi; Kalman Toth; Eszter Szabados
Journal:  JIMD Rep       Date:  2011-09-06

2.  Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.

Authors:  Xinbo Ji; Lizhen Zhao; Kunqian Ji; Yuying Zhao; Wei Li; Rui Zhang; Ying Hou; Jianqiang Lu; Chuanzhu Yan
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

3.  Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome.

Authors:  Ruth Belostotsky; Efrat Ben-Shalom; Choni Rinat; Rachel Becker-Cohen; Sofia Feinstein; Sharon Zeligson; Reeval Segel; Orly Elpeleg; Suheir Nassar; Yaacov Frishberg
Journal:  Am J Hum Genet       Date:  2011-01-20       Impact factor: 11.025

4.  Neurogenetics in Argentina: diagnostic yield in a personalized research based clinic.

Authors:  Sergio Alejandro Rodríguez-Quiroga; Marta Cordoba; Dolores González-Morón; Nancy Medina; Patricia Vega; Cecilia Vazquez Dusefante; Tomoko Arakaki; Nélida Susana Garretto; Marcelo Andres Kauffman
Journal:  Genet Res (Camb)       Date:  2015       Impact factor: 1.588

Review 5.  Biochemical diagnosis of mitochondrial disorders.

Authors:  Richard J T Rodenburg
Journal:  J Inherit Metab Dis       Date:  2010-05-04       Impact factor: 4.982

6.  Haematological abnormalities in mitochondrial disorders.

Authors:  Josef Finsterer; Marlies Frank
Journal:  Singapore Med J       Date:  2015-07       Impact factor: 1.858

7.  MSeqDR: A Centralized Knowledge Repository and Bioinformatics Web Resource to Facilitate Genomic Investigations in Mitochondrial Disease.

Authors:  Marni J Falk; Xiaowu Gai; Lishuang Shen; Maria Angela Diroma; Michael Gonzalez; Daniel Navarro-Gomez; Jeremy Leipzig; Marie T Lott; Mannis van Oven; Douglas C Wallace; Colleen Clarke Muraresku; Zarazuela Zolkipli-Cunningham; Patrick F Chinnery; Marcella Attimonelli; Stephan Zuchner
Journal:  Hum Mutat       Date:  2016-03-21       Impact factor: 4.878

Review 8.  Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disorders.

Authors:  Linda Cassis; Elisenda Cortès-Saladelafont; Marta Molero-Luis; Delia Yubero; Maria Julieta González; Aida Ormazábal; Carme Fons; Cristina Jou; Cristina Sierra; Esperanza Castejon Ponce; Federico Ramos; Judith Armstrong; M Mar O'Callaghan; Mercedes Casado; Raquel Montero; Silvia Meavilla-Olivas; Rafael Artuch; Ivo Barić; Franco Bartoloni; Cinzia Maria Bellettato; Fedele Bonifazi; Adriana Ceci; Ljerka Cvitanović-Šojat; Christine I Dali; Francesca D'Avanzo; Ksenija Fumic; Viviana Giannuzzi; Christina Lampe; Maurizio Scarpa; Ángels Garcia-Cazorla
Journal:  Orphanet J Rare Dis       Date:  2015-12-30       Impact factor: 4.123

Review 9.  Electron Transport Disturbances and Neurodegeneration: From Albert Szent-Györgyi's Concept (Szeged) till Novel Approaches to Boost Mitochondrial Bioenergetics.

Authors:  Levente Szalárdy; Dénes Zádori; Péter Klivényi; József Toldi; László Vécsei
Journal:  Oxid Med Cell Longev       Date:  2015-08-02       Impact factor: 6.543

10.  Defective Expression of the Mitochondrial-tRNA Modifying Enzyme GTPBP3 Triggers AMPK-Mediated Adaptive Responses Involving Complex I Assembly Factors, Uncoupling Protein 2, and the Mitochondrial Pyruvate Carrier.

Authors:  Ana Martínez-Zamora; Salvador Meseguer; Juan M Esteve; Magda Villarroya; Carmen Aguado; J Antonio Enríquez; Erwin Knecht; M-Eugenia Armengod
Journal:  PLoS One       Date:  2015-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.